Isabelle Soubeyran is an expert in Oncology at Institut Bergonié (France). Isabelle Soubeyran has authored 186 publications, the most recent in 2026, and is an investigator in 5 clinical trials. SLR score: 532 (community average: 125). How the SLR is computed.

LeadR Profile

Isabelle Soubeyran Institut Bergonié France
532 ScienceLeadR Reputation 532
Network Map

Oncology

Subspecialties: Genetics - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1996 - 2026

Source: PubMed

Institut Bergonié

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 186

Citations

Citations: 4 881 1st author: 6 Last author: 11 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Serial circulating tumour DNA monitoring in first-line advanced NSCLC (COPE): a randomized, two-arm non-comparative phase II trial.
PMID 42905748 — neoplasms, carcinoma, non-small-cell lung, therapeutics, tissues, plasma
Clin Cancer Res20260
Corrigendum to "Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis" The Lancet Regional Health - Europe, Volume 60, January 2026, 101524.
PMID 42529191 — neoplasms
Lancet Reg Health Eur20260
Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors from Whole-Slide Images.
PMID 42258704 — gastrointestinal stromal tumors, neoplasms, exons, deep learning, protein-tyrosine kinases, tyrosine, therapeutics, learning, mutation, landslides
Cancer Res20260
Technical recommendations from a large-scale French Delphi consensus: A step toward European harmonization of ctDNA analysis.
PMID 42190398 — research design, biopsy, liquid biopsy
Eur J Cancer20260
Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.
PMID 41674582 — gastrointestinal stromal tumors, neoplasms, pathology, exons, deep learning, protein-tyrosine kinases, tyrosine, therapeutics, learning, mutation, landslides
medRxiv20260

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2
Phase 1/Phase 2 1
Phase 2 1
Phase 3 1

By status:

Completed 3
Recruiting 1
Terminated 1

By type:

Interventional 5

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 2
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map